Toutes les actualités
Clinically proven benefits of AI in radiology in 2025
Blog
September 16, 2025

Clinically proven benefits of AI in radiology in 2025

Radiology departments are struggling with a persistent case backlog. The worth of artificial intelligence (AI) in radiology is becoming ever more important as imaging volumes mount, the supply of radiologists decreases, and clinical teams must report quickly and accurately like never before.

Medical imaging teams are operating under constant pressure to balance quality and effectiveness with limited resources.

This is why radiology’s adoption of AI is becoming essential since it has clinical and operational benefits for patients and radiology teams.

AI is no longer a nascent concept; it is a production-deployed technology already complementing outcomes in hospitals and imaging centers. With worklist triage and automation of repetitive tasks, the flagging of critical findings, and auto-populating structured reports, AI makes it possible for radiologists to focus subspecialty expertise where it matters the most: patient care.

Here we look at the top benefits of AI in radiology, with practical examples of how these promises are applied in day-to-day imaging workflows by radiologists.

Benefit 1: AI-Driven Triage of Time-Critical Studies

In emergency departments or in trauma workflows, time is often critical.

Computer-aided detection/triage (CADe/CADt) systems will automatically prioritize studies on the worklist with suspected osseous fractures, pneumothorax, or pleural effusion so that these are escalated to the top of the worklist over less emergent cases.

For instance, AZtrauma identifies fractures, dislocations, and joint effusions on X-rays, and AZchest identifies and classifies essential thoracic findings; both are products within the Rayvolve® suite and use sophisticated AI algorithms to bring to light important findings so they are never overshadowed by routine examinations.

This is very common during overnight coverage or in teleradiology cases when very few radiologists are on duty.

A multi-reader study published in Diagnostics (MDPI) indicates that implementing AI software such as AZchest reduces time to interpret chest X-rays by 35.81%. The specificity, noted in the study, further increased significantly by 11.44%.

By positioning critical cases to the forefront of the worklist, AI allows radiologists to spend their time where it will be most productive.

Benefit 2: Gains in Diagnostic Accuracy and Reader Consistency

Even skilled radiologists will miss diagnoses when working under very short time frames. But AI avoids this possibility.

The AI systems are trained on millions of annotated images and act as a safety net to reduce false positives and add consistency across readers. Rather than replacing radiologists, AI provides a concurrent second reader to pick up on things the human eye might miss on a busy evening. For instance, AZtrauma has enabled radiologists to achieve a 67% of false negatives per case.

Similarly, AZmeasure, the other module in the family of Rayvolve®, offers automated osteo-articular geometry characterization with length and angular position measurement—tasks prone to human variability. Through the provision of immediate, repeatable measurements, it increases the reliability of postoperative imaging follow-up evaluation and preoperative planning.

Benefit 3: Earlier Detection of Subtle Radiographic Findings

Some abnormalities are easy to miss until they become clinically obvious.

AI may identify subtle radiographic findings like microfractures, subcentimeter pulmonary nodules, or early pleural effusions even before symptoms are present. AZchest may spot cardiomegaly or pleural effusion at an earlier stage, before initial treatment is precluded. And the advantage of AI is not only in chest imaging but also in MSK imaging, as noted above.

AZmed's algorithm identified 174 of 182 fractures with 95.6% sensitivity and 91.64% specificity in a clinical study and performed equally well with pediatric radiologists and significantly better than emergency physicians and junior residents. It even identified three fractures missed by pediatric radiologists in their first survey.

This medical imaging technology has direct applications in child health in the case of early diagnosis.

For example, AZboneage, as part of the Rayvolve® family, extends the benefits of early detection to pediatric imaging by automating bone age assessment in hand X-rays. Through the Greulich & Pyle method, it offers a direct skeletal-to-chronological-age comparison in support of the early diagnosis and the direction of timely treatment.

This applies AI to aid early detection not only to boost diagnostic accuracy but also to facilitate anticipatory treatment and potentially circumvent developmental problems and realize enhanced outcomes in patient recovery.

Benefit 4: Reduced Report Turnaround Time (TAT)

Benefits of AI in radiology are also in reducing turnaround time and burnout among radiologists. Through AI assistance, both objectives are fulfilled by cutting down on time-consuming processes and by allowing radiologists to spend time on the critical parts of their profession.

AI has the potential to significantly shorten time from image capture to final report. For instance:

AZtrauma has reduced turnaround times by 83% (from 48h to 8.3h) by detecting and highlighting fractures.

AZchest, as mentioned above, interprets chest X-rays 35.8% faster while retaining high sensitivity and specificity.

AZmeasure eliminates the need for manual MSK measurements and provides repeatable and accurate results instantly.

They enable faster diagnosis for patients in less time, prompt clinical teams to act on results without unnecessary delays, and help radiologists maintain focus and continuity.

Benefit 5: Standardized Reporting and Workflow Integration

Inconsistent reporting is likely to impede patient care and lead to confusion among teams. AI overcomes this by providing standardized radiology reports in an unequivocal and consistent presentation of results.

AZmed's Rayvolve® portfolio is AI-powered and built for vendor-neutral PACS/RIS integration. It seamlessly integrates into PACS/RIS and displays AI outputs as DICOM secondary captures/overlays, so radiologists can view these results in conjunction with the initial images without departing from their typical workflow. This easy integration allows departments to realize benefits from machine learning intelligence without further steps or disruption.

But to achieve these advantages in full measure, radiology groups need AI products that are clinically validated, FDA-cleared, and CE marked.

Applying AZmed to Implement AI into the Practice of Radiology Departments

Among the biggest worries about implementing AI in radiology is the fact that, although hundreds of products are available, very few are FDA-cleared or carry the CE marking. AZmed's products achieve both and are evidence of compliance with regulatory formality and clinical disclosure.

AZtrauma and AZchest* are FDA-cleared and CE-marked and have proven deployment in >2,500 sites worldwide.

AZmeasure and AZboneage are CE-marked and extend their value from emergency diagnosis to orthopedic planning to childhood growth measurement.

Here you will find papers, performance indicators, and clinical adoption metrics: AZmed Scientific Evidence.

Hospitals and health centers globally are already experiencing the benefits of radiology-anchored artificial intelligence.

Interested in how these products fit into your workflow? Get a demo to discover the suite of products in Rayvolve® and how it supports increased speed, accuracy, and patient outcomes in ways that will never necessitate an upgrade to other systems.

FAQs

  1. What is radiology AI and how is it used in clinical practice?
    Radiology AI refers to software that analyzes medical images to assist with detection, triage, quantification, and reporting. The most effective tools integrate directly into PACS/RIS so they fit existing workflows without adding extra steps.

  2. How does radiology AI integrate with PACS and RIS in a vendor-neutral way?
    Vendor-neutral integration means the AI reads and writes DICOM to any standards-compliant PACS/RIS, presenting results as overlays or structured fields without forcing a new viewer. Seamless workflow fit is critical to realize clinical value.

  3. Does radiology AI replace radiologists?
    No. Current systems augment clinicians by prioritizing studies, flagging findings, and standardizing measurements while final responsibility stays with human readers. Teams that combine clinical and AI expertise deliver the best results.

  4. What clinical benefits does AI provide in radiology departments?
    Common benefits include shorter turnaround time, improved reader consistency, and better worklist triage for time-sensitive cases such as suspected fractures or pneumothorax. The gains come when tools are embedded in routine workflows.

  5. What evidence is required to trust a radiology AI solution?
    Look for prospective and multi-center validations tied to critical-to-quality metrics, plus continuous monitoring for model drift after go-live. Real-world evidence complements trials because AI evolves faster than traditional studies.

  6. How does AI improve diagnostic accuracy without increasing false positives?
    Validated systems act as a concurrent second reader trained on curated datasets, improving sensitivity and reader consistency while requiring governance to manage liability and oversight.

  7. What is worklist triage and why does it matter?
    Worklist triage automatically orders studies so suspected critical findings appear first, ensuring the right case reaches a clinician at the right time. The best insights are ineffective if they arrive too late.

  8. How should hospitals evaluate return on investment for radiology AI?
    Tie ROI to measurable outcomes like reduced TAT, fewer re-reads, and operational efficiencies in scheduling and throughput. Many providers expect ROI within a year when operational improvements accompany clinical use.

  9. What are the main barriers to adopting AI in radiology?
    Barriers include workflow misfit, integration gaps, data quality issues, clinician trust in black-box systems, and unclear liability frameworks. Organizational readiness often lags behind adoption pressure.

  10. How do bias and fairness affect radiology AI performance?
    Models trained on narrow populations can underperform in underrepresented groups or low-resource settings, creating inequity. Improving data context and diversity is essential to safe deployment.

  11. What is explainability in radiology AI and why is it important?
    Explainability provides interpretable outputs and rationale so clinicians and patients understand how AI influenced a decision. Opaque systems undermine trust in high-stakes imaging.

  12. How should health systems govern clinical risk from AI?
    Use accountable oversight with defined responsibilities, performance monitoring, and escalation paths. Black-box behavior and hallucinations require safety nets and human-in-the-loop controls.

  13. What role does interoperability play in successful AI deployments?
    Interoperability is foundational. If systems do not exchange data reliably, AI insights cannot be delivered where care decisions occur, limiting impact regardless of algorithm quality.

  14. Can AI help radiology services in low- and middle-income countries?
    AI can expand access, but success depends on adapting to local data, infrastructure, and workflows. Many models trained on Western datasets fail to generalize without localization.

  15. Beyond image interpretation, where does AI add value in imaging?
    Major gains often occur in operations such as scheduling, billing, capacity planning, and supply chain, reducing bottlenecks and costs while supporting clinical work.

  16. What cybersecurity risks accompany AI in radiology?
    Increased connectivity and automation create new attack surfaces, including risks of model extraction and data reconstruction. Security and privacy controls must evolve with deployment.

  17. What is multimodal healthcare AI and why is it relevant to radiology?
    Multimodal systems combine images with reports, labs, and clinical context, outperforming single-source models and supporting pathway-level decisions across the enterprise.

  18. How should clinicians and IT teams collaborate on imaging AI?
    Effective programs pair clinical problem framing and ground truthing with engineering, regulatory, and operational expertise from concept to product. Education on both sides accelerates adoption.

  19. How does AI support value-based imaging care?
    By reducing delays, improving accuracy, and streamlining pathways, AI contributes to technical value, allocative value, and better patient outcomes without adding to the workflow burden.

  20. What should a hospital include in an AI procurement checklist for radiology?
    Require vendor-neutral PACS/RIS integration, validated performance on your case mix, explainability features, drift monitoring, security assurances, and a plan for clinician training and change management.

EU - Rayvolve: Medical Device Class IIa in Europe (CE 2797) in compliance with the Medical Device Regulation (2017/745). Rayvolve is a computer-aided diagnosis tool, intended to help radiologists and emergency physicians to detect and localize abnormalities on standard X-rays.

US - Medical device Class II according to the 510K clearances. Rayvolve: is a computer-assisted detection and diagnosis (CAD) software device to assist radiologists and emergency physicians in detecting fractures during the review of radiographs of the musculoskeletal system. Rayvolve is indicated for the adult and pediatric population (≥ 2 years).

Rayvolve PTX/PE: is a radiological computer-assisted triage and notification software that analyzes chest x-ray images of patients 18 years of age or older for the presence of pre-specified suspected critical findings (pleural effusion and/or pneumothorax). Rayvolve LN: is a computer-aided detection software device to assist radiologists to identify and mark regions in relation to suspected pulmonary nodules from 6 to 30mm size of patients of 18 years of age or older

Caution: The data mentioned are sourced from internal documents, internal studies and literature reviews. This material with associated pictures is non-contractual. Carefully read the instructions for use before use. Please refer to our Privacy policy on our website For more information, please contact contact@azmed.co.

AZmed 10 rue d’Uzès, 75002 Paris - www.azmed.co - RCS Laval B 841 673 601

© 2025 AZmed – All rights reserved. MM-25-27

* AZchest is CE-marked for detection of abnormalties on chest X-rays such as: consolidation, pleural effusion, pneumothorax, cardiomegaly, acute pulmonary edema, ribs fractures and pulmonary nodules. It’s also FDA-cleared for two applications: detection of lung nodules (with Rayvolve LN) and notification and triage for pneumothorax and pleural effusion (with Rayvolve PTX-PE)

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Articles connexes

Afficher toutes les preuves scientifiquesAfficher toutes les actualités

Optimisez votre flux de travail et améliorez la qualité des soins avec AZmed

Découvrez la puissance de notre suite d'IA dès aujourd'hui